These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cotrimoxazole prophylaxis for infants exposed to HIV infection. Graham SM Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259 [No Abstract] [Full Text] [Related]
3. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847 [TBL] [Abstract][Full Text] [Related]
4. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Gill CJ; Sabin LL; Tham J; Hamer DH Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886 [TBL] [Abstract][Full Text] [Related]
7. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. ; Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907 [No Abstract] [Full Text] [Related]
8. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations. Gaut P; Daar ES Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888 [No Abstract] [Full Text] [Related]
9. P. carinii pneumonia in African children and the ineffectiveness of TMP-SMX prophylaxis. Cruciani M; Malena M; Mengoli C Clin Infect Dis; 2003 Apr; 36(7):937-9; author reply 939-40. PubMed ID: 12652402 [No Abstract] [Full Text] [Related]
10. Effective alternates to trimethoprim-sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: are there any? Ramesh M; Chandrasekar PH Pediatr Transplant; 2008 Dec; 12(8):823-6. PubMed ID: 18518908 [No Abstract] [Full Text] [Related]
11. Pneumocystis pneumonia in children receiving chemotherapy. Prasad P; Nania JJ; Shankar SM Pediatr Blood Cancer; 2008 Apr; 50(4):896-8. PubMed ID: 17458875 [TBL] [Abstract][Full Text] [Related]
12. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Higgins RM; Bloom SL; Hopkin JM; Morris PJ Transplantation; 1989 Mar; 47(3):558-60. PubMed ID: 2646786 [No Abstract] [Full Text] [Related]
13. Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both? Hudson CP; Roach TC Int J STD AIDS; 2003 Sep; 14(9):644-5. PubMed ID: 14511507 [No Abstract] [Full Text] [Related]
14. Discontinuing prophylaxis against Pneumocystis carinii pneumonia. Bender MA; Sax PE N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364 [No Abstract] [Full Text] [Related]
15. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients. Lindemulder S; Albano E Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548 [TBL] [Abstract][Full Text] [Related]
16. Pneumocystis pneumonia prophylaxis in children. Am Fam Physician; 1991 Jun; 43(6):2269-70. PubMed ID: 2042558 [No Abstract] [Full Text] [Related]
17. PCP prophylaxis in perinatally HIV-exposed infant. Shahid SK Indian Pediatr; 2008 Nov; 45(11):939; discussion 939-40. PubMed ID: 19029576 [No Abstract] [Full Text] [Related]